Cefluprenam
Alternative Names: E 1077Latest Information Update: 11 Jan 2002
At a glance
- Originator Eisai Co Ltd
- Class Cephalosporins; Small molecules
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 11 Jan 2002 No-Development-Reported for Bacterial infections in USA (Parenteral)
- 30 Aug 1999 Discontinued-preregistration for Bacterial infections in Japan (Parenteral)
- 30 Jul 1997 Preregistration for Bacterial infections in Japan (Parenteral)